EP3139168A4 - Method for assaying creatine kinase mb isozyme and kit to be used therein - Google Patents
Method for assaying creatine kinase mb isozyme and kit to be used therein Download PDFInfo
- Publication number
- EP3139168A4 EP3139168A4 EP15785419.1A EP15785419A EP3139168A4 EP 3139168 A4 EP3139168 A4 EP 3139168A4 EP 15785419 A EP15785419 A EP 15785419A EP 3139168 A4 EP3139168 A4 EP 3139168A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- isozyme
- kit
- creatine kinase
- assaying creatine
- assaying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000004420 Creatine Kinase Human genes 0.000 title 1
- 108010042126 Creatine kinase Proteins 0.000 title 1
- 108010044467 Isoenzymes Proteins 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
- G01N21/82—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a precipitate or turbidity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
- G01N33/545—Synthetic resin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- G01N2333/91205—Phosphotransferases in general
- G01N2333/9123—Phosphotransferases in general with a nitrogenous group as acceptor (2.7.3), e.g. histidine kinases
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plasma & Fusion (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014093351 | 2014-04-30 | ||
PCT/JP2015/061350 WO2015166790A1 (en) | 2014-04-30 | 2015-04-13 | Method for assaying creatine kinase mb isozyme and kit to be used therein |
Publications (3)
Publication Number | Publication Date |
---|---|
EP3139168A1 EP3139168A1 (en) | 2017-03-08 |
EP3139168A4 true EP3139168A4 (en) | 2017-10-11 |
EP3139168B1 EP3139168B1 (en) | 2018-12-12 |
Family
ID=54358525
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP15785419.1A Active EP3139168B1 (en) | 2014-04-30 | 2015-04-13 | Method for assaying creatine kinase mb isozyme and kit to be used therein |
Country Status (8)
Country | Link |
---|---|
US (1) | US20170122943A1 (en) |
EP (1) | EP3139168B1 (en) |
JP (1) | JP6515923B2 (en) |
KR (1) | KR102331684B1 (en) |
CN (1) | CN106461662B (en) |
ES (1) | ES2708781T3 (en) |
TW (1) | TWI679421B (en) |
WO (1) | WO2015166790A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6862845B2 (en) * | 2016-01-22 | 2021-04-21 | 日立化成ダイアグノスティックス・システムズ株式会社 | Method for measuring soluble interleukin-2 receptor and reagent for measurement |
JP2018173334A (en) * | 2017-03-31 | 2018-11-08 | 株式会社シマ研究所 | Method for immunological measurement and reagent kit used for the same |
CN108548926B (en) * | 2018-03-22 | 2019-11-08 | 北京九强生物技术股份有限公司 | A kind of creatine kinase isozyme detection kit |
CN113125721B (en) * | 2019-12-31 | 2023-07-07 | 科美博阳诊断技术(上海)有限公司 | Homogeneous detection kit for creatine kinase isozymes and application thereof |
CN113125700B (en) * | 2019-12-31 | 2023-08-08 | 科美博阳诊断技术(上海)有限公司 | Homogeneous detection kit for creatine kinase isozymes and application thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1986000992A1 (en) * | 1984-07-30 | 1986-02-13 | Shah Vipin D | Two site enzyme labeled cross reaction immunometric sandwich assay method |
WO1987003094A1 (en) * | 1985-11-14 | 1987-05-21 | Washington University | Creatine kinase mb determination method |
DE4314254A1 (en) * | 1993-04-30 | 1994-11-03 | Boehringer Mannheim Gmbh | Monoclonal antibodies to CK-MB |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62157571A (en) * | 1985-12-20 | 1987-07-13 | イ−・アイ・デユポン・ド・ネモア−ス・アンド・コンパニ− | Method of testing immunity of ck-mb |
US4810639A (en) * | 1985-12-20 | 1989-03-07 | E. I. Du Pont De Nemours And Company | Immunoassay for CK-MB using bound and soluble antibodies |
JP4455767B2 (en) * | 1999-01-19 | 2010-04-21 | シスメックス株式会社 | Creatine kinase isozyme assay and reagent |
CN1908628A (en) * | 2006-08-10 | 2007-02-07 | 福建省洪诚生物药业有限公司 | Chemical luminescent detecting method of creatine kinase isozyme in serum |
CN102435738A (en) * | 2011-08-31 | 2012-05-02 | 内蒙古科慧生物科技有限责任公司 | Creatine kinase isoenzyme (CK-MB) quantitative determination kit and detection method thereof |
JP2013125005A (en) | 2011-12-16 | 2013-06-24 | Mitsubishi Chemical Medience Corp | Latex agglutination immunoreagent for ck-mb measurement and measuring method |
CN102809651B (en) * | 2012-07-26 | 2015-07-15 | 博奥赛斯(天津)生物科技有限公司 | Creatine phosphokinase isozyme chemiluminescence immune quantitative detection kit and preparation method thereof |
JP2015061350A (en) * | 2013-09-17 | 2015-03-30 | トヨタ自動車株式会社 | Smoothing circuit for vehicle |
-
2015
- 2015-04-13 US US15/301,847 patent/US20170122943A1/en not_active Abandoned
- 2015-04-13 KR KR1020167015499A patent/KR102331684B1/en active IP Right Grant
- 2015-04-13 WO PCT/JP2015/061350 patent/WO2015166790A1/en active Application Filing
- 2015-04-13 JP JP2016515921A patent/JP6515923B2/en active Active
- 2015-04-13 EP EP15785419.1A patent/EP3139168B1/en active Active
- 2015-04-13 CN CN201580021649.4A patent/CN106461662B/en active Active
- 2015-04-13 ES ES15785419T patent/ES2708781T3/en active Active
- 2015-04-24 TW TW104113135A patent/TWI679421B/en active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1986000992A1 (en) * | 1984-07-30 | 1986-02-13 | Shah Vipin D | Two site enzyme labeled cross reaction immunometric sandwich assay method |
WO1987003094A1 (en) * | 1985-11-14 | 1987-05-21 | Washington University | Creatine kinase mb determination method |
DE4314254A1 (en) * | 1993-04-30 | 1994-11-03 | Boehringer Mannheim Gmbh | Monoclonal antibodies to CK-MB |
Non-Patent Citations (3)
Title |
---|
See also references of WO2015166790A1 * |
U WÜRZBURG ET AL: "Quantitative Determination of Creatine Kinase Isoenzyme Catalytic Concentrations in Serum Using Immunological Methods 1 )", J. CLIN. CHEM. CLIN. BIOCHEM, 1 January 1977 (1977-01-01), pages 131 - 137, XP055401539, Retrieved from the Internet <URL:http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.632.7534&rep=rep1&type=pdf> * |
URI PIRAN ET AL: "ImmunochemiluminometricAssay of Creatine Kinase MB with a MonoclonalAntibody to the MB Isoenzyme", CLIN. CHEM. CLINICAL CHEMISTRY, 1 January 1987 (1987-01-01), pages 1517 - 1, XP055401211, Retrieved from the Internet <URL:http://clinchem.aaccjnls.org/content/clinchem/33/9/1517.full.pdf> * |
Also Published As
Publication number | Publication date |
---|---|
JP6515923B2 (en) | 2019-05-22 |
EP3139168B1 (en) | 2018-12-12 |
CN106461662B (en) | 2019-06-18 |
JPWO2015166790A1 (en) | 2017-04-20 |
CN106461662A (en) | 2017-02-22 |
EP3139168A1 (en) | 2017-03-08 |
KR102331684B1 (en) | 2021-11-25 |
US20170122943A1 (en) | 2017-05-04 |
ES2708781T3 (en) | 2019-04-11 |
TWI679421B (en) | 2019-12-11 |
KR20160146641A (en) | 2016-12-21 |
WO2015166790A1 (en) | 2015-11-05 |
TW201621319A (en) | 2016-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL248299B (en) | A method and kit for determining the tissue or cell origin of dna | |
EP3303636A4 (en) | Companion methods and kits for il-2-based therapies and mesenchymal stem cell-based therapies | |
EP3212225A4 (en) | Methods and compositions for modified t cells | |
EP3161161A4 (en) | Methods and compositions for sample analysis | |
EP3134722A4 (en) | Reagent cartridge and methods for detection of cells | |
EP3101115A4 (en) | Biomolecule analysis kit and biomolecule analysis method | |
EP2964785B8 (en) | Method and kit for characterizing microorganisms | |
EP3160361A4 (en) | Analysis cartridge and method for using same | |
EP3150704A4 (en) | Culture method and cell mass | |
EP3217458A4 (en) | State determination device and method for fuel cell | |
EP3115450A4 (en) | Cell culture method and cell culture device | |
EP3252141A4 (en) | Cell culturing method and kit | |
EP3139163A4 (en) | Immunochromotographic analysis kit, immunochromotographic analysis device, and immunochromotographic analysis method | |
EP3473727A4 (en) | Method for analyzing state of cells in spheroid | |
EP3107996A4 (en) | Tscm cells and methods for use | |
EP3298151A4 (en) | Methods and composition for determining ph | |
EP3158330A4 (en) | Apparatuses and methods for determining analyte charge | |
EP3144315A4 (en) | Enzyme-specific fluorescent compound capable of being retained in cells | |
EP3166630A4 (en) | Vaccines against an oncogenic isoform of esr1 and methods of using the same | |
EP3149212A4 (en) | Electrochemical methods and compounds for the detection of enzymes | |
EP3227476A4 (en) | Methods and kits for theranostic applications | |
EP3200509A4 (en) | Cell access method and device | |
EP3128003A4 (en) | Medium for stem cell use | |
EP3139168A4 (en) | Method for assaying creatine kinase mb isozyme and kit to be used therein | |
EP3199637A4 (en) | Electrochemical measuring method and electrochemical measuring device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20160923 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20170911 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: G01N 33/543 20060101ALI20170905BHEP Ipc: G01N 33/573 20060101AFI20170905BHEP Ipc: G01N 33/545 20060101ALI20170905BHEP Ipc: G01N 21/82 20060101ALI20170905BHEP |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20180601 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: FUJIFILM WAKO PURE CHEMICAL CORPORATION |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAJ | Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted |
Free format text: ORIGINAL CODE: EPIDOSDIGR1 |
|
GRAL | Information related to payment of fee for publishing/printing deleted |
Free format text: ORIGINAL CODE: EPIDOSDIGR3 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
GRAR | Information related to intention to grant a patent recorded |
Free format text: ORIGINAL CODE: EPIDOSNIGR71 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
INTC | Intention to grant announced (deleted) | ||
INTG | Intention to grant announced |
Effective date: 20181024 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1076708 Country of ref document: AT Kind code of ref document: T Effective date: 20181215 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: VALIPAT S.A. GEVERS SA, CH |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602015021527 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PCAR Free format text: NEW ADDRESS: RUE DES NOYERS 11, 2000 NEUCHATEL (CH) |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2708781 Country of ref document: ES Kind code of ref document: T3 Effective date: 20190411 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20181212 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181212 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190312 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181212 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181212 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181212 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190312 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1076708 Country of ref document: AT Kind code of ref document: T Effective date: 20181212 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190313 Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181212 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181212 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181212 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181212 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181212 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181212 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190412 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181212 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190412 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181212 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181212 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181212 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602015021527 Country of ref document: DE |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181212 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181212 Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181212 |
|
26N | No opposition filed |
Effective date: 20190913 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20190430 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190413 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181212 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190430 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181212 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190413 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181212 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181212 Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20150413 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181212 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R081 Ref document number: 602015021527 Country of ref document: DE Owner name: FUJIFILM CORPORATION, JP Free format text: FORMER OWNER: FUJIFILM WAKO PURE CHEMICAL CORPORATION, OSAKA-SHI, OSAKA, JP |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230515 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: 732E Free format text: REGISTERED BETWEEN 20230706 AND 20230712 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: PC2A Owner name: FUJIFILM CORPORATION Effective date: 20240408 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20240229 Year of fee payment: 10 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20240313 Year of fee payment: 10 Ref country code: FR Payment date: 20240308 Year of fee payment: 10 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20240227 Year of fee payment: 10 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20240501 Year of fee payment: 10 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20240507 Year of fee payment: 10 |